Additionally, NBEAL1 has been shown to regulate SREBP2 processing and cholesterol metabolism [53], suggesting that SV52610, located within the potential regulatory sequence of NBEAL1, could be considered a good candidate polymorphism affecting the gene expression of NBEAL1 associated with coronary artery disease. Here, SREBF2 is linked to coronary artery disorder.